Table: Rohto - 6-MTH group results
Nov 13 (Reuters)-
Rohto Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2019 Sep 30, 2018 Mar 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 90.43 87.26 184.00
(+3.6 pct) (+11.2 pct) (+0.2 pct)
Operating 10.39 10.71 21.50
(-3.0 pct) (+23.7 pct) (+3.3 pct)
Recurring 10.88 11.08 21.30
(-1.8 pct) (+26.6 pct) (+12.3 pct)
Net 7.31 7.32 13.50
(-0.2 pct) (+29.6 pct) (+37.8 pct)
EPS 64.07 yen 64.22 yen 118.35 yen
EPS Diluted 63.86 yen 63.96 yen
Ann Div 25.00 yen 26.00 yen
-Q2 div 13.00 yen 11.00 yen
-Q4 div 14.00 yen 13.00 yen
NOTE - Rohto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T